Journal Home > Volume 1 , Issue 2
Health Care Science 2022, 1(2): 129-133 https://doi.org/10.1002/hcs2.20
Commentary | Open Access | Issue | Published: 12 October 2022

Monkey pox: Rethinking COVID‐19 to project future strategies against emerging and evolving pathogens

Show Author's Information Emmanuel Lamptey1 ( ),  Stanley Yaidoo2,  Ernestina Asiedua3,  Evans Osei Boakye4,  Moses tia Banoya5,  Ephraim Kumi Senkyire6
Institute of Life and Earth Sciences (Including Health and Agriculture), Pan African University, University of Ibadan, Ibadan, Nigeria
St. Gregory Catholic Hospital, Central Region, Gomoa East District, Buduburam, Ghana
University of Ghana, Legon, Ghana
Department of Social Work, University of Ghana, Legon, Ghana
Methodist University Ghana, Accra, Ghana
Ga‐West Municipal Hospital, Ghana Health Service, Accra, Ghana
Keywords:
infectious, COVID‐19, monkey pox, pandemic
Cite this article:
Lamptey E, Yaidoo S, Asiedua E, et al. Monkey pox: Rethinking COVID‐19 to project future strategies against emerging and evolving pathogens. Health Care Science, 2022, 1(2): 129-133. https://doi.org/10.1002/hcs2.20
Download citation
EndNote(RIS)
BibTeX

423

Views

7

Downloads

Citations

0

Crossref

N/A

WoS

0

Scopus

N/A

CSCD

Full text About this article

menu
Full text
Outline
About this article

Monkey pox: Rethinking COVID‐19 to project future strategies against emerging and evolving pathogens

Show Author's information Emmanuel Lamptey1 ( ), Stanley Yaidoo2, Ernestina Asiedua3, Evans Osei Boakye4, Moses tia Banoya5, Ephraim Kumi Senkyire6
Institute of Life and Earth Sciences (Including Health and Agriculture), Pan African University, University of Ibadan, Ibadan, Nigeria
St. Gregory Catholic Hospital, Central Region, Gomoa East District, Buduburam, Ghana
University of Ghana, Legon, Ghana
Department of Social Work, University of Ghana, Legon, Ghana
Methodist University Ghana, Accra, Ghana
Ga‐West Municipal Hospital, Ghana Health Service, Accra, Ghana
Keywords: infectious, COVID‐19, monkey pox, pandemic

References(36)

Syropoulos S, Markowitz EM. Prosocial responses to COVID‐19: examining the role of gratitude, fairness and legacy motives. Pers Individ Dif. 2021;171:110488.
DOI Google Scholar
Wagner AF. What the stock market tells us about the post‐COVID‐19 world. Nat Hum Behav. 2020;4(5):440. 10.1038/s41562-020-0869-y
DOI Google Scholar
Shanahan L, Steinhoff A, Bechtiger L, Murray AL, Nivette A, Hepp U, et al. Emotional distress in young adults during the COVID‐19 pandemic: evidence of risk and resilience from a longitudinal cohort study. Psychol Med. 2022;52(5):824–33.
DOI Google Scholar
Moore R, Zielinski MJ, Thompson RG, Willis DE, Purvis RS, McElfish PA. “This pandemic is making me more anxious about my welfare and the welfare of others:” COVID‐19 stressors and mental health. Int J Environ Res Public Health. 2021;18(11):5680.
DOI Google Scholar
Park CL, Russell BS, Fendrich M, Finkelstein‐Fox L, Hutchison M, Becker J. Americans' COVID‐19 stress, coping, and adherence to CDC guidelines. J Gen Intern Med. 2020;35(8):2296–303.
DOI Google Scholar
Choi S‐Y. Industry volatility and economic uncertainty due to the COVID‐19 pandemic: evidence from wavelet coherence analysis. Finance Res Lett. 2020;37:101783. 10.1016/j.frl.2020.101783
DOI Google Scholar
WHO | Regional Office for Africa. COVID‐19 vaccines. https://www.afro.who.int/health-topics/coronavirus-covid-19/vaccines. Accessed June 25, 2022.10.1016/j.lana.2021.100176
DOI
OECD. The impact of COVID‐19 on health and health systems. https://www.oecd.org/health/covid-19.htm. Accessed June 22, 2022.
Science, L. S. of E. and P. The impact of COVID‐19 on global health. London School of Economics and Political Science. https://www.lse.ac.uk/Events/2022/02/202202161700/impact.aspx. Accessed June 22, 2022.
Kim D. Minimizing public health consequences of the COVID‐19 pandemic: let's consider the threat of a triple recession. Lancet Reg Health Am. 2022;8:100176.
DOI Google Scholar
Workie E, Mackolil J, Nyika J, Ramadas S. Deciphering the impact of COVID‐19 pandemic on food security, agriculture, and livelihoods: a review of the evidence from developing countries. Curr Res Environ Sustain. 2020;2:100014. 10.1016/j.crsust.2020.100014
DOI Google Scholar
Zaidi A. Living under the shadow of a pandemic: the psychological challenges underlying social distancing and awareness raising. Psychol Trauma: Theory Res Pract Policy. 2020;12(5):508–10. 10.1037/tra0000815
DOI Google Scholar
Allocati N, Petrucci AG, Di Giovanni P, Masulli M, Di Ilio C, De Laurenzi V. Bat–man disease transmission: zoonotic pathogens from wildlife reservoirs to human populations. Cell Death Discov. 2016;2(1):1–8.
DOI Google Scholar
Ahmed M, Naseer H, Arshad M, Ahmad A. Monkeypox in 2022: a new threat in developing. Ann Med Surg. 2022;78:103975.
DOI Google Scholar
WHO. Monkeypox. https://www.who.int/news-room/fact-sheets/detail/monkeypox. Retrieved August 10, 2022.10.1371/journal.pntd.0010141
DOI
Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypox—a potential threat? A systematic review. PLoS Neglected Trop Dis. 2022;16(2):e0010141.
DOI Google Scholar
Taylor L. Monkeypox: WHO declares a public health emergency of international concern. BMJ. 2022;378:o1874.
DOI Google Scholar
FDA. FDA approves first COVID‐19 vaccine. FDA. August 23, 2021. https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine
Were the COVID‐19 vaccines rushed? Here's how the vaccines were developed so fast. https://www.nebraskamed.com/COVID/were-the-covid-19-vaccines-rushed. Accessed June 25, 2022.
COVID‐19 vaccine: how was it developed so fast? November 13, 2021. https://www.medicalnewstoday.com/articles/how-did-we-develop-a-covid-19-vaccine-so-quickly
European Centre for Disease Prevention and Control. Non‐pharmaceutical interventions against COVID‐19. https://www.ecdc.europa.eu/en/covid-19/prevention-and-control/non-pharmaceutical-interventions. Accessed August 10, 2022.10.1038/d41586-022-00215-2
DOI
Jonathan and Karin Fielding School of Public Health. An infection anywhere is a potential infection everywhere. https://ph.ucla.edu/news/news-item/2021/may/infection-anywhere-potential-infection-everywhere. Accessed June 26, 2022.
DOI
Yale Medicine. 5 things to know about the delta variant. https://www.yalemedicine.org/news/5-things-to-know-delta-variant-covid. Accessed October 1, 2021.10.1038/d41586-021-02383-z
DOI
Techonomy. ‘An infection anywhere is potentially an infection everywhere’: preparing for the next pandemic. May 3, 2021. https://techonomy.com/infection-anywhere-potentially-infection-everywhere-preparing-next-pandemic/
Mallapaty S. Where did Omicron come from? Three key theories. Nature. 2022;602(7895):26–8.
DOI Google Scholar
Multi‐country monkeypox outbreak in non‐endemic countries. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON385. Accessed June 26, 2022.
Oxfam International. COVID‐19 death toll four times higher in lower‐income countries than rich ones. March 3, 2022. https://www.oxfam.org/en/press-releases/covid-19-death-toll-four-times-higher-lower-income-countries-rich-ones
Levin AT, Owusu‐Boaitey N, Pugh S, Fosdick BK, Zwi AB, Malani A, et al. Assessing the burden of COVID‐19 in developing countries: systematic review, meta‐analysis and public policy implications. BMJ Glob Health. 2022;7(5):e008477.
DOI Google Scholar
COVID‐19 contributions tracker. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/donors-and-partners/funding. Accessed June 26, 2022.
Maxmen A. The fight to manufacture COVID vaccines in lower‐income countries. Nature. 2021;597(7877):455–7.
DOI Google Scholar
Adebisi T, Aregbesola A, Asamu F, Arisukwu O, Oyeyipo E. Using SNSs for early detection of disease outbreak in developing countries: evidence from COVID‐19 pandemic in Nigeria. Heliyon. 2021;7(6):e07184.
DOI Google Scholar
CDC. COVID data tracker. Centers for Disease Control and Prevention. March 28, 2020. https://covid.cdc.gov/covid-data-tracker
DOI
Vaccine equity. https://www.who.int/campaigns/vaccine-equity. Accessed June 26, 2022.
CEPI. New Vaccines for a safer world. https://cepi.net/. Accessed June 26, 2022.
Broniatowski DA, Dredze M, Ayers JW. “First do no harm”: effective communication about COVID‐19 vaccines. Am J Public Health. 2021;111(6):1055–7.
DOI Google Scholar
The Health Foundation. Who is most vulnerable to health‐related misinformation about COVID‐19? https://www.health.org.uk/news-and-comment/blogs/who-is-most-vulnerable-to-health-related-misinformation-about-covid-19. Accessed June 26, 2022.
Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 04 July 2022
Accepted: 24 August 2022
Published: 12 October 2022
Issue date: October 2022

Copyright

© 2022 The Authors.

Acknowledgements

None.

Rights and permissions

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Return